Usability of the PreView PHP for Home Use in Intermediate AMD Patients
NCT ID: NCT00776451
Last Updated: 2009-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
66 participants
OBSERVATIONAL
2008-11-30
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients
NCT00748384
PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization
NCT00358345
Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration
NCT01334294
Age-Related Macular Degeneration (AMD) - Usability Study
NCT00963339
Usage of the Home Macular Perimeter (HMP)
NCT00596388
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Subjects diagnosed with Dry AMD
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥65 years
* VA with habitual correction better than 20/60 in the study eye
* Ability to speak, read and understand instructions in English or Hebrew
* Qualified to use the device by health care professional
Exclusion Criteria
* Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy, CFP.
* Any non-macular related ocular surgery or macular surgery performed within 3 months prior to study entry in the target eye
* Participation in another study with the exclusion of AREDS study
* Patients diagnosed with geographic atrophy (GA)
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Notal Vision Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Notal Vision
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neil Bressler, Prof.
Role: PRINCIPAL_INVESTIGATOR
JHMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Belinson Medical Center
Petah Tikva, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
sponsor web site
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHP-US-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.